Dynamic Technology Lab’s Arbutus Biopharma ABUS Stock Holding History

Dynamic Technology Lab’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75K	Buy	+15,604	New	+$68.5K	0.02%	604
2026 Q1	–	Sell	-25,779	Closed	-$124K	–	833
2025 Q4	$124K	Buy	+25,779	New	+$116K	0.03%	664
2023 Q1	–	Sell	-13,630	Closed	-$32K	–	1030
2022 Q4	$32K	Sell	13,630 -4,892	-26%	-$11.7K	﹤0.01%	1033
2022 Q3	$35K	Buy	18,522 +1,194	+7%	+$2.81K	﹤0.01%	1068
2022 Q2	$47K	Sell	17,328 -48,248	-74%	-$123K	0.01%	1029
2022 Q1	$195K	Buy	+65,576	New	+$201K	0.02%	948
2017 Q1	–	Sell	-40,017	Closed	-$98K	–	932
2016 Q4	$98K	Buy	+40,017	New	+$116K	0.03%	811

Other funds holding ABUS

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM

Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dynamic Technology Lab's ABUS Position: Q2 2026 in Review

Dynamic Technology Lab opened a new position in Arbutus Biopharma (ABUS) in Q2 2026: 15,604 shares worth $75K. The stake represents 0.02% of the portfolio and ranks #604 among its holdings. This is a return to the name: Dynamic Technology Lab previously reported a position in ABUS as recently as Q4 2025.

Dynamic Technology Lab first reported a position in ABUS in Q4 2016 and has held it in 7 quarters since. The position peaked at $195K in Q1 2022. 177 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

Dynamic Technology Lab held 15,604 shares of Arbutus Biopharma worth $75K as of Q2 2026.
Arbutus Biopharma was a new Dynamic Technology Lab position in Q2 2026.
Arbutus Biopharma made up 0.02% of Dynamic Technology Lab's portfolio in Q2 2026, its #604 holding.
Dynamic Technology Lab first reported a position in Arbutus Biopharma in Q4 2016 and has held it in 7 quarters since.
Dynamic Technology Lab's Arbutus Biopharma position peaked at $195K in Q1 2022.
177 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.